8
Oct
2024

CanSino Biologics Inc.

Exhibitor at CPHI Milan 2024 stand 14F37, Finished Dosage Formulations
About Us

Incorporated in 2009, CanSinoBIO (SSE: 688185, HKEX: 06185) commits to providing high-quality, innovative, and affordable vaccines for global public health security. It possesses five integrated platform technologies upon which the company has established a rich portfolio of a pipeline products preventing more than 10 diseases. CanSinoBIO has established a rich portfolio of a pipeline products preventing more than ten diseases, including COVID-19, Ebola virus disease, tuberculosis, meningitis, pertussis, diphtheria, tetanus, shingles etc.

  • CN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Technology
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 14F37, Finished Dosage Formulations

Products Featured at CPHI Milan 2024